HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG) - ANVISA Registration 81325990116

Access comprehensive regulatory information for HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81325990116 and manufactured by ACRO BIOTECH, INC. (MONTCLAIR). The registration is held by QR CONSULTING, IMPORTACAO E DISTRIBUICAO DE PRODUTOS MEDICOS LTDA with validity until Mar 23, 2030.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT IRELAND DIAGNOSTICS DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81325990116
2 Related Devices
Registration Details
ANVISA Registration Number: 81325990116
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Família Teste rápido em cassete de HBsAg (Sangue Total/Soro/Plasma)
Risk Class IV

Registration Details

81325990116

25351511217201918

19933144000129

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Mar 23, 2020

23/03/2030

09/18/2025 19:00:01

Família Teste rápido em cassete de HBsAg (Sangue Total/Soro/Plasma)
Risk Class IV

Registration Details

81325990116

25351511217201918

19933144000129

Dates and Status

Mar 23, 2020

23/03/2030

09/18/2025 19:00:01